RPD Fund Management LLC, along with RPD Opportunity Fund LP, RPD Opportunity LLC, and Ahmet H. Okumus, collectively hold a 9.1% stake in Appian Corporation. This filing indicates a shift in ownership, with RPD Fund Management LLC now holding 3,900,656 shares, representing 9.1% of the company's Class A Common Stock. The...

This filing details the beneficial ownership of Avalo Therapeutics, Inc. common stock by Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander. As of February 24, 2026, Millennium Management LLC reported beneficial ownership of 934,429 shares, representing 5.0% of the class. This ownership...

Fourth Sail Capital LP, along with Ariel Merenstein, Fourth Sail Capital US LP, Tordesilhas Capital Gestora De Recursos Ltda., and Fourth Sail Long Short LLC, has filed a Schedule 13G indicating beneficial ownership of 6.21% of CALAVO GROWERS INC ordinary shares. The total number of shares beneficially owned is 1,109,3...

Commodore Capital LP, along with its affiliates Commodore Capital Master LP, Michael Kramarz, and Robert Egen Atkinson, has reported acquiring a 9.9% stake in IMMUNIC, INC. (IMUX). The total beneficial ownership amounts to 13,350,121 shares of common stock. This acquisition includes shares underlying pre-funded warrant...

This filing reports that Paradigm BioCapital Advisors LP, along with Paradigm BioCapital Advisors GP LLC, Senai Asefaw, M.D., and Paradigm BioCapital International Fund Ltd., collectively hold a 5.1% stake in EyePoint, Inc. as of February 17, 2026. The total number of shares beneficially owned by Paradigm BioCapital Ad...

Felix Holdings B.V. has acquired a significant stake in TRUPANION, INC., now beneficially owning 4,296,538 shares, representing 9.89% of the company's outstanding common stock. This acquisition occurred on February 17, 2026, with the filing dated February 24, 2026. The shares were not acquired for the purpose of influe...

Fourth Sail Capital LP, along with Ariel Merenstein, Fourth Sail Capital US LP, Tordesilhas Capital Gestora De Recursos Ltda., and Fourth Sail Long Short LLC, has filed a Schedule 13G indicating beneficial ownership of 6.21% of CALAVO GROWERS INC ordinary shares. The total number of shares beneficially owned is 1,109,3...

Trails Edge Capital Partners, LP, along with Trails Edge Biotechnology Master Fund, LP, and Ortav Yehudai, reported beneficial ownership of 11,454,000 shares of Immunic, Inc. common stock as of February 17, 2026. This constitutes 8.7% of the outstanding shares. The ownership is primarily held through pre-funded warrant...

Commodore Capital LP, along with its affiliates Commodore Capital Master LP, Michael Kramarz, and Robert Egen Atkinson, has reported acquiring a 9.9% stake in IMMUNIC, INC. (IMUX). The total beneficial ownership amounts to 13,350,121 shares of common stock. This acquisition includes shares underlying pre-funded warrant...

Integrated Core Strategies (US) LLC, along with Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander, has reported a 9.6% ownership of Spruce Biosciences, Inc. common stock. This filing, a Schedule 13G, indicates that as of February 17, 2026, Integrated Core Strategies (US) LLC beneficial...

Springhouse Capital Management, LP, along with its affiliated entities and Brian Gaines, has reported beneficial ownership of 905,874 shares of Lovesac Co. common stock, representing 6.2% of the class. Brian Gaines individually holds 918,674 shares, constituting 6.28% ownership. This filing, dated February 24, 2026, pe...

This filing details the beneficial ownership of Avalo Therapeutics, Inc. common stock by Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander. As of February 24, 2026, Millennium Management LLC reported beneficial ownership of 934,429 shares, representing 5.0% of the class. This ownership...

This SEC filing (SCHEDULE 13G) reports that the MainStreet Bank 401(k) Retirement Plan, managed by Richard A. Vari as Administrator, has acquired beneficial ownership of 383,763 shares of MainStreet Bancshares, Inc. Common Stock. This represents 5.1% of the class, with shared voting and dispositive power of 383,763. Th...

This SEC filing (SCHEDULE 13G) reports that the MainStreet Bank 401(k) Retirement Plan, managed by Richard A. Vari as Administrator, has acquired beneficial ownership of 383,763 shares of MainStreet Bancshares, Inc. Common Stock. This represents 5.1% of the class, with shared voting and dispositive power of 383,763. Th...

Streeterville Capital LLC, along with Streeterville Management LLC and John M. Fife, reported beneficial ownership of 1,846,854 Class A Ordinary Shares of NetClass Technology Inc. as of February 24, 2026. This represents 9.99% of the outstanding shares. The ownership is subject to a contractual cap of 9.99% due to righ...

This filing reports that Paradigm BioCapital Advisors LP, along with Paradigm BioCapital Advisors GP LLC, Senai Asefaw, M.D., and Paradigm BioCapital International Fund Ltd., collectively hold a 5.1% stake in EyePoint, Inc. as of February 17, 2026. The total number of shares beneficially owned by Paradigm BioCapital Ad...

Nicholas Peters has acquired beneficial ownership of 1,161,049 shares of QHSLab, Inc. common stock, representing 8.65% of the total shares outstanding. This acquisition was made in the ordinary course of business and not with the purpose of influencing or changing control of the issuer. Peters holds sole and shared vot...

Nicholas Peters has acquired beneficial ownership of 1,161,049 shares of QHSLab, Inc. common stock, representing 8.65% of the total shares outstanding. This acquisition was made in the ordinary course of business and not with the purpose of influencing or changing control of the issuer. Peters holds sole and shared vot...

RPD Fund Management LLC, along with RPD Opportunity Fund LP, RPD Opportunity LLC, and Ahmet H. Okumus, collectively hold a 9.1% stake in Appian Corporation. This filing indicates a shift in ownership, with RPD Fund Management LLC now holding 3,900,656 shares, representing 9.1% of the company's Class A Common Stock. The...

Integrated Core Strategies (US) LLC, along with Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander, has reported a 9.6% ownership of Spruce Biosciences, Inc. common stock. This filing, a Schedule 13G, indicates that as of February 17, 2026, Integrated Core Strategies (US) LLC beneficial...

Springhouse Capital Management, LP, along with its affiliated entities and Brian Gaines, has reported beneficial ownership of 905,874 shares of Lovesac Co. common stock, representing 6.2% of the class. Brian Gaines individually holds 918,674 shares, constituting 6.28% ownership. This filing, dated February 24, 2026, pe...

Streeterville Capital LLC, along with Streeterville Management LLC and John M. Fife, has filed a Schedule 13G regarding their beneficial ownership of X3 Holdings Co., Ltd. ordinary shares. As of February 24, 2026, Streeterville Capital LLC directly beneficially owns 2,048,722 shares, representing 9.99% of the outstandi...

Streeterville Capital LLC, along with Streeterville Management LLC and John M. Fife, reported beneficial ownership of 1,846,854 Class A Ordinary Shares of NetClass Technology Inc. as of February 24, 2026. This represents 9.99% of the outstanding shares. The ownership is subject to a contractual cap of 9.99% due to righ...

Felix Holdings B.V. has acquired a significant stake in TRUPANION, INC., now beneficially owning 4,296,538 shares, representing 9.89% of the company's outstanding common stock. This acquisition occurred on February 17, 2026, with the filing dated February 24, 2026. The shares were not acquired for the purpose of influe...

Trails Edge Capital Partners, LP, along with Trails Edge Biotechnology Master Fund, LP, and Ortav Yehudai, reported beneficial ownership of 11,454,000 shares of Immunic, Inc. common stock as of February 17, 2026. This constitutes 8.7% of the outstanding shares. The ownership is primarily held through pre-funded warrant...